Vimarsana
Biggest News Aggregation in the World

Page 8 - Mark Lebwohl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Lebwohl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Lebwohl Today - Breaking & Trending Today

Newly published trial results showed spesolimab significantly improved signs and symptoms of flare in rare, life-threatening skin disease, generalised - Vimarsana News

Newly published trial results showed spesolimab significantly improved signs and symptoms of flare in rare, life-threatening skin disease, generalised

Newly published trial results showed spesolimab significantly improved signs and symptoms of flare in rare, life-threatening skin disease, generalised pustular psoriasis New clinical trial data published today in the New England Journal of Medicine, showed that spesolimab, a novel IL-36R antibody treatment, was...

Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor - Vimarsana News

Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor

Complete clearance of pustules in half of patients in 1 week with spesolimab

American Skin Association Announces Research Achievement Awards - Vimarsana News

American Skin Association Announces Research Achievement Awards

American Skin Association Announces Research Achievement Awards AMY S. PALLER, MD 2021 RECIPIENT OF DAVID MARTIN CARTER MENTOR AWARD News provided by Share this article Share this article 2021 David Martin Carter Mentor Award and the 2021 Research Achievement Awards. For over three decades, ASA's David Martin Carter Mentor Award has honored members of the dermatology community who embody the characteristics that made the late Dr. David Martin Carter an inspiration to dermatologists, investigators, and medical students throughout the world. Dr. Carter and ASA's late founder, Dr. George Hamb...

New psoriasis drug shows 'night and day difference' in clinical trials - Vimarsana News

New psoriasis drug shows 'night and day difference' in clinical trials

New psoriasis drug shows 'night and day difference' in clinical trials By (0) A new drug was more effective at treating the symptoms of psoriasis than two other currently available drugs, according to two recent clinical trials. Photo by Psoriasis-Netz/Flickr A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials. There was a "night and day difference" in the results from bimekizumab compared against two established psoriasis drugs, secukinumab, or Cosentyx, and adalimumab, or...

Source: upi.com
Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021 - Vimarsana News

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021 Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that two abstracts from Dermavant's two pivotal Phase 3 trials for tapinarof for the treatment of psoriasis in adults, PSOARING 1 and PSOARING 2, will be presented during the upcoming American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), on April 23-25, 2021. Tapinarof is being developed as a novel, once-daily th...